Praxis Precision Medicines Inc’s recent filing unveils that its General Counsel and Secretary Nemiroff Alex unloaded Company’s shares for reported $0.66 million on Nov 14 ’24. In the deal valued at $80.20 per share,8,239 shares were sold. As a result of this transaction, Nemiroff Alex now holds 10,301 shares worth roughly $0.37 million.
Then, Mastrocola Lauren sold 5,188 shares, generating $424,318 in total proceeds. Upon selling the shares at $81.78, the Principal Accounting Officer now owns 5,613 shares.
Before that, Mastrocola Lauren bought 5,189 shares. Praxis Precision Medicines Inc shares valued at $424,316 were divested by the Officer at a price of $81.77 per share.
H.C. Wainwright reiterated its Praxis Precision Medicines Inc [PRAX] rating to a Buy in a research note published on March 03, 2025; the price target was $105. A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. Oppenheimer began covering PRAX with “an Outperform” recommendation on August 05, 2024. Needham started covering the stock on June 24, 2024. It rated PRAX as “a Buy”.
Price Performance Review of PRAX
On Tuesday, Praxis Precision Medicines Inc [NASDAQ:PRAX] saw its stock fall -5.28% to $35.87. Over the last five days, the stock has gained 0.03%. Praxis Precision Medicines Inc shares have fallen nearly -53.39% since the year began. Nevertheless, the stocks have fallen -41.22% over the past one year. While a 52-week high of $91.83 was reached on 02/14/25, a 52-week low of $30.01 was recorded on 03/04/25. SMA at 50 days reached $59.79, while 200 days put it at $61.53.
Levels Of Support And Resistance For PRAX Stock
The 24-hour chart illustrates a support level at 34.18, which if violated will result in even more drops to 32.49. On the upside, there is a resistance level at 37.68. A further resistance level may holdings at 39.49. The Relative Strength Index (RSI) on the 14-day chart is 32.63, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.16%. Stochastics %K at 65.96% indicates the stock is a holding.
How much short interest is there in Praxis Precision Medicines Inc?
A steep rise in short interest was recorded in Praxis Precision Medicines Inc stocks on 2025-03-14, dropping by -0.61 million shares to a total of 2.06 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.67 million shares. There was a decline of -29.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 18, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $155 price target.
